Maywell Health · Leadership · Confidential

P&L Forecast & Patient Growth

Sep 2026 → Aug 2028 · Rebuilt 2026-08-30 from the full Chase record (operating account + both cards, Jan 2025 → Aug 2026), the Athena CPT payment export (26,063 paid lines, remit dates, rendering provider), the payroll register, the supply export, the NY WC fee schedule, the 8-30 IDR dispute report and the referral exports. Every driver traces to a source; assumptions are tagged.
REBUILT 31 AUG 2026. The revenue engine now runs on one referral-fed demand pool capped by room capacity and valued at a blended $/visit (the payer mix of the referring source sets the rate: NF $227 · Medicare $204 · Commercial $189 · WC $124 · lien $24) — replacing four additive provider volume lines. Headline range: FY1 OCF $302K at $186/visit · ~$393K at the observed ~$195 · $631K at $220. David FY2: cash $714,450 (range $570–714K pending his OR grid), production $904,970. PA revenue is folded into the pool (incident-to at 100% under Dr. Mayrsohn’s NPI). Detailed tables below this banner predate the rebuild where they disagree — the workbook MAYWELL_CASHFLOW_MODEL_2026-08-30.xlsx and MAYWELL_MODEL_CHANGELOG_2026-08-31.md govern. Growth story: referral acquisition and conversion, not hiring — the practice is demand-constrained from spring 2027.
$2.82–$3.16M
FY1 revenue — rebuilt 31 Aug on the demand-pool architecture ($186–$220/visit)
$2,516,912
FY1 total cost (incl. office manager, stepped NYC rent)
$302K–$631K
FY1 operating cash flow — conservative to lag-adjusted; ~$393K at the observed $195/visit
11–20%
FY1 operating margin by rate scenario
$1,078,758
of it arbitration (30%)
$26,744
FY1 OCF if arbitration fails
Aug 2027
First month a $300K take-home is covered
12,694
FY1 kept visits
128.7
New patients/mo, trailing 3 (was 151.4)
60.3%
Booking conversion, Jul (Athena) · 63.3% Jun
1,537
Referred and never booked

The one thing to understand before anything else

On your own assumptions, the entire profit of this business for the next twelve months is the arbitration recovery. FY1 revenue is $3,618,880, of which $1,078,758 — 30% — is arbitration. Strip both tracks and operating cash flow falls from $1,105,502 to $26,744. The core practice, with two PAs and a $20K rent base, runs at breakeven. Everything above breakeven is money currently sitting unpaid in a queue.

By FY2 that improves — the core practice throws off $260,748 once David is at plateau and the PA pod has matured — but for the next twelve months, arbitration is the profit.

That is not an argument against the forecast. The assumptions are yours and they are defensible. It is an argument about where the attention goes — and the lane that carries 30% of FY1 revenue is staffed by one contractor at 42 hours a month.

Two things the growth data says that the forecast does not assume away

New patient flow is falling. Practice-wide new patients ran 151.4/month trailing-12 and 128.7/month trailing-3 — down 15%. Revenue growth here comes from visits already booked, the PA pod, and arbitration. It does not come from more new patients, because there are not more new patients.

Two of the three growing channels are the ones that pay worst. Jason Brown / CCC books at 33.5%, the worst named converter in the book, and is up from 6.3 to 16.3/month. Morgan & Morgan — the attorney/lien channel — is up from 8.2 to 10.0. Meanwhile the referring-physician network is shrinking on almost every name.

The arbitration basis — your assumptions, 2026-08-30

Both lanes are driven from the Drivers tab. Change a rate and the whole model moves.
LanePopulationBasisValue
Track B — WC / No-Fault4,052 unpaid lines, $5,116,084 charged
98% matched to a listed CPT
33% of the WC fee schedule
8-month average pay from 1 Sep 2026 → centred May 2027
$737,978 at schedule
$243,533 expected
Track A — OON / IDR2,800 unpaid lines across 1,967 claims, $3,241,947 charged50% of claims collect, drawn at random
seed 20260830 → 984 claims, $1,694,313 of charges (52.3%), × 96.8% collection on award
$1,640,095 expected
Combined6,852 unpaid procedure lines$1,883,628
The one risk this basis does not price: filing deadlines. The 984 randomly drawn OON claims have a median age of 279 days and a p75 of 543. By age band: 33.0% of the selected charges are inside 90 days, 12.8% are 91–180, 20.7% are 181–365, and 33.6% are over a year old. No Surprises Act IDR windows are short — open negotiation within 30 business days of the initial payment or denial, then four business days to initiate. On the face of it roughly $570K of the $1.64M is likely time-barred. There is a driver on the Drivers tab (Haircut for time-barred claims, currently 0%) to price it once counsel gives a view.

The P&L

Cash basis — this is a medical practice, revenue is recognised when it reaches the bank. FY1 = Sep 2026 → Aug 2027. FY2 = Sep 2027 → Aug 2028, the first full year with David Jevotovsky.
LineFY1per monthFY2per monthchange
REVENUE
Core practice — Mayrsohn panel$2,326,523$193,877$2,178,308$181,526-6%
PA pod — Shivani + Jessica$213,600$17,800$345,600$28,800+62%
Arbitration — Track A, OON / IDR$875,814$72,984$693,289$57,774-21%
Arbitration — Track B, WC / No-Fault$202,944$16,912$40,589$3,382-80%
Total revenue$3,618,880$301,573$4,066,286$338,857+12%
PEOPLE
W-2 payroll incl. employer burden$1,054,836$87,903$1,086,481$90,540+3%
Contractors (1099)$114,562$9,547$117,999$9,833+3%
Shivani (PA)$130,000$10,833$130,000$10,833+0%
Jessica (PA)$124,000$10,333$150,000$12,500+21%
David Jevotovsky — base$0$0$335,000$27,917new
David Jevotovsky — production bonus$0$0$96,460$8,038new
Total people$1,423,398$118,616$1,915,940$159,662+35%
OPERATING
Rent & occupancy$224,000$18,667$240,000$20,000+7%
Clinical services vendors$220,572$18,381$227,189$18,932+3%
Medical supplies$38,082$3,174$51,321$4,277+35%
IDR / arbitration filing fees$30,410$2,534$31,323$2,610+3%
Athena / practice management$137,517$11,460$154,519$12,877+12%
Software & admin$96,449$8,037$99,343$8,279+3%
Insurance$52,646$4,387$54,226$4,519+3%
Legal & professional$24,328$2,027$25,058$2,088+3%
Contractors & reimbursements$71,160$5,930$73,295$6,108+3%
Business spend on the cards$151,954$12,663$156,513$13,043+3%
Credit-card interest$2,433$203$2,506$209+3%
U.S. Bank financing$40,428$3,369$40,428$3,369+0%
Total operating$1,089,981$90,832$1,155,720$96,310+6%
OPERATING CASH FLOW, before owner comp$1,105,502$92,125$994,626$82,886-10%
Operating margin30.5%24.5%
Kept visits12,6941,05817,1071,426+35%
Revenue per visit$285$238

FY1 month by month

Cash in, cash out, and the operating result. The September dip is Shivani starting and rent stepping to $12K in the same month; November is the step to $20K.
Patient growth — where the patients actually come from

New patients per month, by channel

SOURCED: referral exports Aug 2025 → Jul 2026. Trailing-3 against trailing-12 is the trend column. Booking rate and visits-per-patient are lifetime, from the funnel cut.
ChannelLifetimeAug 25SepOctNovDecJan 26FebMarAprMayJunJulT3/moT12/moTrendBookingVisits/pt
Zocdoc782202324161422919329353827.321.8UP57.9%5.5
Quantum PT273231930715123518172112713.318.0DOWN71.8%4.4
Jason Brown / CCC16412330536413191716.36.3UP33.5%6.9
Morgan & Morgan102128111189118915610.08.2UP60.8%4.0
Word of Mouth14510658839745264.36.1DOWN57.2%5.1
Google / Web1197557653992554.05.7DOWN53.8%4.8
Dr. Jason Tam492452652123685.73.8UP
Dr. Mayrsohn / self-ref135612104420245503.34.5DOWN77.0%5.0
Dr. Rohan Desai1148494517432201.34.1DOWN71.1%6.7
Dr. Stephanides785876324650121.04.1DOWN57.7%6.5
ALL SOURCES175170221136174134127144150107142137128.7151.4DOWN61.3%5.7

The two curves that matter

Zocdoc is carrying the practice. Quantum PT — the single largest assumption in the Jevotovsky underwriting — is falling.

The growth story, stated honestly

Zocdoc is the engine. 782 lifetime patients, trailing-3 at 27.3/month against a trailing-12 of 21.8, and 35 then 38 in the last two months. It books at 57.9% and delivers 5.5 visits per kept patient. It is the only large channel that is clearly accelerating on its own.

Quantum PT is falling, and the Jevotovsky case rests on it. The ramp case assumes 21 patients/month from Quantum for David alone — a quarter of his target panel. The trailing-12 is 18.0 and the trailing-3 is 13.3, with the last two months at 12 and 7. That is not a rounding difference; it is the largest single input to the deal moving the wrong way while the deal is being negotiated.

The physician network is decaying. Desai (relocating, known), Stephanides, Alcarez, Shah, self-referral — all down. The corpus already named the mechanism: reciprocity. Organisations Maywell refers to send back 37.5 patients on average; those it does not send to average 12.8. Maywell has sent 132 patients out in its entire history, about 4/month. Outbound referral volume is the leading indicator, and inbound lags it by four months.

Growth is concentrating in the channels that pay worst. Jason Brown / CCC is up from 6.3 to 16.3/month and books at 33.5%, the worst named converter in the book. Morgan & Morgan is up from 8.2 to 10.0 — the attorney/lien channel, where the Athena data shows Self-Pay/NF/lien collecting at 7.8% of charges against 8.7% practice-wide, and taking a 42-day median to pay against 16 days for Medicare.

The booking funnel — measured, and leaking

SOURCED: the monthly referral reports and their matching no-appointment reports. This is the count of patients referred against the count who ever got an appointment.
MonthReferredBookedNever bookedBooking rate
June 2026166897753.6%
July 2026149727760.3%
Corpus baseline, 2026-08-1661.3%
Booking conversion has fallen 13 points. Roughly half of everyone referred never gets an appointment. At 149 referrals a month, at about 200 referrals a month each point of conversion is roughly 2 patients, and each patient is 5.7 visits at $224 — so a point is worth about $2,530 a month, or $30,400 a year. Conversion is not collapsing: July reads 60.3% and June 63.3% against 61.3% lifetime. The prize is lifting a stable number — 60.3% to 70% is worth about $295,000 a year on referrals you are already paying to generate.

The unbooked backlog

SOURCED: provider referral export, every patient flagged with no next appointment. Registration dates Jun 2025 → Aug 2026.
Age since registrationPatientsShareOf which *SELF PAY*
0–90 days20613.4%63%
91–180 days18011.7%58%
181–365 days42727.8%56%
1–2 years53835.0%48%
2 years+18612.1%45%
Total referred and never booked1,53753%
386 of them registered within the last 180 days — the live recovery list. The corpus recorded 444 under 180 days on 2026-08-16; it is now 386, which means the list is being worked slowly or not at all. At 5.7 visits and $224 a visit: 20% recovery on the live list is $98,569; 20% across the whole 1,537 is $392,488. The model carries this lane at a 0% recovery rate — it is an opportunity, not a plan, and nothing in the forecast depends on it.

Outbound effort — the leading indicator

SOURCED: Sara's weekly activity log, 45 weeks, plus the targeted-referral tracker.
MeasureValueRead
Touchpoints logged344Text 123 · in-person 78 · email 55 · phone 36 · dinner 6
To organisations that have referred116Reciprocity maintenance
To organisations that never have74Prospecting
Targeted contacts on the list311
Referrals those contacts produced, May + June41
Contacts producing zero28190%
The effort is real — 344 logged touches is not a coverage problem. The conversion is the problem: 90% of targeted contacts produced nothing across two months. The ramp case names this as the leading indicator for David's panel, because inbound lags outbound by four months. It also names the mechanism: organisations Maywell refers to send back 37.5 patients on average against 12.8 for those it does not. Maywell has sent 132 patients out in its entire history, about 4 a month.
The second interventionalist

David Jevotovsky — the ramp, and what the AlFarra precedent says about it

Ramp case 2026-08-30: plateau 113 visits/week at month six, 4,168 year-one visits, $220/visit, ladder opens $650,000, break-even $865,884.
Referral channel for DavidRamp case assumesActual, trailing 3GapBasis
Quantum / Birnhak21 /mo13.3 /mo−7.7VERIFIED — falling
Zocdoc share15 /mo27.3 /mo totalheadroomVERIFIED — rising
Other existing referrals12 /monetwork shrinkingVERIFIED
Paid search @ $2k/mo6 /monot yet runningMODELED, $250–400 CAC
Subtotal vs the 80/mo he needs54 /mogap 26/mo≈9 new sources at 3/mo

The AlFarra precedent — the thing the term sheet has to fix

AlFarra is the only second-interventionalist data that exists. Rendering-provider data, Jul 2025 → Jan 2026: 1,036 lines, 655 claims, $1,228,211 charged, $86,614 collected — a 7.1% yield, $132 per claim. Against a ramp case that plans David at $220/visit.

His book was 69% *SELF PAY* by charges — $845,356 charged, $60,695 collected. That is the No-Fault and lien population, exactly what the ramp case means when it calls David's panel "Quantum-heavy, 71% NF/WC."

And the compensation structure is the real lesson. Per the corpus, AlFarra started on 50% of collections; that failed precisely because his patients were liens and no-fault requiring arbitration that Maywell had no implementation for. So the deal was changed to 95% of expected collections, paid out on a fee schedule. Valuing his lines at the NY WC schedule gives $153,193; at 95% that is roughly $145,533 paid against $86,614 collected — about 1.7× . The January 25, 2026 written agreement then became the subject of a four-month payment dispute.

So the David term sheet has to pay on cash, not on expected. The ramp case already flags that §2 pays only on services personally performed — that fixes attribution. It does not fix the basis. Paying a percentage of expected collections on a panel that is 71% NF/WC is precisely how the practice paid AlFarra 1.7× what it collected on him.

The gap is closable, and arbitration is what closes it. AlFarra has $521,080 of unpaid procedure charges. At the corpus's NF arbitration rate of 8.5% that recovers $44,292 and lifts him to $200/claim; at 10.2% he reaches $213. The $220 plan rate is reachable — but only through the arbitration lane, worked properly.

What has to be true

1 · Arbitration has to actually run. It is 21% of FY1 revenue and it is staffed by one contractor at 334 hours year-to-date — about 42 hours a month. $163,500 of awards are won and unpaid, four are past their payment window and one is 251 days old. This is the highest value-per-hour work in the business and it is the thinnest resourced.

2 · The PA pod has to produce. Modelled at $120 per visit, sourced from Timoney's 351 mature claims — 54% of Mayrsohn's $224. Shivani and Jessica still have zero billing lines, so nothing about them is measurable yet. Fixing rendering-provider attribution is the precondition for everything else on this page.

3 · Quantum has to be redirected, or replaced. 13.3/month and falling against 21 assumed. Nine new sources at 3/month each is the stated plan; new relationships reach 5+/month in a median of four months, so autumn seeding produces before September 2027 — but only if the seeding starts.

4 · Outbound referrals have to reach 20+/month. Currently ~4. This is the leading indicator for everything in the growth table, and inbound lags it by four months.

5 · New patient flow has to stop falling. 128.7/month against 151.4 trailing-12. Nothing in this forecast assumes it recovers — but nothing in it survives a further decline either.

Sources. Chase 1680 operating account + cards 0736/7247, Jan 2025 → Aug 2026 (August reconciled transaction by transaction, 69 of 69 balances tie) · CPT Analysis - Payment (1).xlsx, 26,063 paid lines with remit dates and rendering provider · Payroll_Summary_Jan-Aug_2026.xlsx · Supply_Expense_by_Location_2026.xlsx · NF_Carrier_Payment_Analysis.xlsx carrier scorecard · NY WC fee schedule Region IV · 8-30-26 IDR dispute report, 111 disputes · referral exports Aug 2025 → Jul 2026 · contractor-payments report 2026 · MAYWELL_JEVOTOVSKY_RAMP_CASE_2026-08-30.md · corpus corrections layer 2026-08-16.
Model. 70_PLANS/MAYWELL_CASHFLOW_MODEL_2026-08-30.xlsx — 9 sheets, every figure a live formula off the Drivers tab. Assumption register in MAYWELL_OWNER_SALARY_MODEL_2026-08-30.md.
Tags. Sourced measured from data · Modeled derived on stated assumptions · Assumed judgement, change first.
Built 2026-08-30 · Maywell Health · Leadership only — do not circulate.